Clinical Trial

CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions

Study acronym: BE-001-2024
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the oral bioavailability of 'CreNeuroS CNS Fish Oil Plus Softgels \[Eicosapentaenoic Acid (as Ethyl Ester) 342 mg; L-5-methyltetrahydrofolate 1.875 mg; other Vitamins and Minerals\] (Test Product) compared with co-administration of Omega-3-acid Ethyl ester 1000 mg Capsules (Reference Product-1) and L-methylfolate Calcium 7.5 mg Capsules (Reference Product-2) in healthy human adult subjects under fasting conditions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-02.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-01-20
Trial Details
NCT Number NCT06758778
Lead Sponsor Sichuan Credit Pharmaceutical Co., Ltd.
Collaborators: Glogen Clinical Research Pvt. Ltd
Conditions Bioavailability
Enrollment 14 participants
Start Date 2025-01-03
Primary Completion 2025-01-03 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2025-01-23